Calbo, Arkisha Kailaia .

HRN: 27-24-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2026
CEFUROXIME 750MG (VIAL)
03/12/2026
03/18/2026
IV
250mg
Q8H
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: